What therapeutic classification does Enalapril Maleate belong to?

What therapeutic classification does Enalapril Maleate belong to?

• A. Calcium Channel Blocker
• B. ACE Inhibitor
• C. Beta Blocker
• D. Diuretic

Answer: (B)

Enalapril Maleate is classified as an ACE inhibitor, which stands for Angiotensin-Converting Enzyme inhibitor. This classification is significant because ACE inhibitors play a crucial role in managing conditions such as hypertension and heart failure. They work by inhibiting the enzyme that converts angiotensin I to angiotensin II, a substance that normally causes blood vessels to constrict. By blocking this conversion, ACE inhibitors like Enalapril promote vasodilation, thereby lowering blood pressure and reducing the workload on the heart. Understanding the mechanism of action and therapeutic uses of ACE inhibitors helps explain why Enalapril is used in treating both high blood pressure and heart conditions. It can also provide benefits in kidney protection, especially in patients with diabetes. Overall, the classification of Enalapril as an ACE inhibitor highlights its vital role in cardiovascular therapy and the management of renal disease.

Enalapril Maleate is classified as an ACE inhibitor, which stands for Angiotensin-Converting Enzyme inhibitor. This classification is significant because ACE inhibitors play a crucial role in managing conditions such as hypertension and heart failure. They work by inhibiting the enzyme that converts angiotensin I to angiotensin II, a substance that normally causes blood vessels to constrict. By blocking this conversion, ACE inhibitors like Enalapril promote vasodilation, thereby lowering blood pressure and reducing the workload on the heart.

Understanding the mechanism of action and therapeutic uses of ACE inhibitors helps explain why Enalapril is used in treating both high blood pressure and heart conditions. It can also provide benefits in kidney protection, especially in patients with diabetes. Overall, the classification of Enalapril as an ACE inhibitor highlights its vital role in cardiovascular therapy and the management of renal disease.